Partners HealthCare Innovation

The record

Every round we can evidence, newest first25 appearances

1. 2019

   3 rounds

2. Sept
   ZielBioSeries A · US · FinSMEs$25MWith 1 other
3. Jul
   Alizé Pharma 3Series A · FR · FinSMEs$74MWith 6 others
4. Apr
   Nocion TherapeuticsSeries A · US · FinSMEs$27MWith 3 others
5. 2017

   1 round

6. May
   Magenta TherpeuticsSeries B · US · FinSMEs$50MWith 5 others
7. 2015

   5 rounds

8. Jun
   SebaciaSeries C · US$12MWith 3 others
9. Jun
   Spero TherapeuticsSeries A · US$30MWith 7 others
10. May
    lifeIMAGEVenture · US$18MWith 5 others
11. Mar
    Daktari DiagnosticsSeries D · US$16MWith 3 others
12. Feb
    Lysosomal TherapeuticsSeries A · US$20MWith 6 others
13. 2014

    2 rounds

14. Oct
    Raze TherapeuticsSeries A · US$24MWith 6 others
15. May
    Lysosomal TherapeuticsSeed · US$4.8MWith 6 others
16. 2013

    2 rounds

17. Nov
    Editas MedicineSeries A · US · finsmes.com$43MWith 3 others
18. Mar
    QPID HealthSeries A · US · finsmes.com$4.0MWith 3 others
19. 2012

    9 rounds

20. Oct
    InStore FinanceDebt · US · freshnews.com$25KSole investor
21. Sept
    Annovation BioPharmaSeries A · US · fiercebiotech.com$8.0MWith 1 other
22. Mar
    via680Seed · US · finsmes.com$100KWith 1 other
23. Mar
    Zuga MedicalSeed · US · finsmes.com$100KWith 1 other
24. Mar
    QuixbyGrant · US · finsmes.com$25KWith 1 other
25. Mar
    ScoreFeederVenture · US · finsmes.com$25KWith 1 other
26. Mar
    TIP ImagingVenture · US · finsmes.com$100KWith 1 other
27. Mar
    Campus ShiftVenture · US · finsmes.com$40KWith 1 other
28. Jan
    RaNA TherapeuticsSeries A · US · masshightech.com$21MWith 2 others
29. 2011

    1 round

30. Dec
    Daktari DiagnosticsVenture · US · finsmes.com$10MWith 2 others
31. 2009

    2 rounds

32. Oct
    Daktari DiagnosticsSeries A · US · onbiovc.com$2.8MWith 5 others
33. Mar
    TargAnoxSeries A · US · xconomy.com$5.1MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.